Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYSLTR2 | Q9NS75 | 8/20 | 0.49 |
| ▸ | CYSLTR1 | Q9Y271 | 8/20 | 0.49 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9579676 | 0.92 | CYSLTR2 (0.47) | CYSLTR2CYSLTR1GRM2 | |
| SCHEMBL9510503 | 0.87 | CYSLTR2 (0.50) | CYSLTR2CYSLTR1GRM2 | |
| SCHEMBL9510405 | 0.85 | GRM2 (0.56) | CYSLTR2CYSLTR1GRM2 | |
| SCHEMBL9558415 | 0.80 | GRM2 (0.55) | CYSLTR2CYSLTR1GRM2 | |
| SCHEMBL9506662 | 0.79 | CYSLTR2 (0.53) | CYSLTR2CYSLTR1GRM2 | |
| SCHEMBL9506959 | 0.79 | CYSLTR2 (0.49) | CYSLTR2CYSLTR1GRM2 | |
| SCHEMBL9558691 | 0.79 | GRM2 (0.56) | CYSLTR2CYSLTR1GRM2 | |
| SCHEMBL9508793 | 0.78 | GRM2 (0.57) | CYSLTR2CYSLTR1GRM2 | |
| SCHEMBL9510563 | 0.78 | GRM2 (0.57) | CYSLTR2CYSLTR1GRM2 | |
| SCHEMBL9506933 | 0.78 | CYSLTR2 (0.52) | CYSLTR2CYSLTR1GRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0310126-B1 | DERIVATIVES OF PYROCATECHOL-CARBOXYLIC ACID, THEIR PREPARATION AND USE AS ACTIVE INGREDIENTS IN MEDICINES | F. HOFFMANN-LA ROCHE AG (CH) | 1993-08-18 | — | — | EP | disclosed |
| US-5191108-A | Lipoxygenase inhibitors, antiinflammatory agents | HOFFMANN-LA ROCHE INC. (US) | 1993-03-02 | — | — | US | disclosed |
| US-5025036-A | Antiinflammatory agents, gastrointestinal, cardiovascular and skin disorders | HOFFMANN-LA ROCHE INC. (US) | 1991-06-18 | — | — | US | disclosed |